PATENT CLAIM ANALYSIS

Application Number: 15963648
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "114000"]

Abstract:
The present invention provides modified metformin compounds, particularly mito-metformin compounds, and pharmaceutical compositions thereof. Methods of using the compounds to provide neuroprotection and in the treatment and/or prevention of neurodegenerative diseases are also described.

Claim (Index 14):
The method of  claim 1 , wherein the method treats a neural injury in a subject having a neurodegenerative disease by administering an effective amount of the neuroprotection composition in order to treat the neural injury.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.22581
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15294083', '15218790', '14656096', '14733185', '13266659']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7579721469384495
- 35 USC 102 Novelty (BERT): 0.6385154656759665
- Combined Prediction Score: 0.7460264788122012
- Mean Citation Score: 344.8929960000001
- Max Citation Score: 613.4918
- Similarity Product: 558.240438624239

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test